Week In Review: Hansoh Signs $456 Million Deal For siRNA Products
October 16, 2021 at 14:29 PM EDT
Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to $450 million in milestones.
